Loreto Martínez‐González

733 total citations
29 papers, 576 citations indexed

About

Loreto Martínez‐González is a scholar working on Molecular Biology, Neurology and Pharmacology. According to data from OpenAlex, Loreto Martínez‐González has authored 29 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Neurology and 10 papers in Pharmacology. Recurrent topics in Loreto Martínez‐González's work include Cholinesterase and Neurodegenerative Diseases (10 papers), Amyotrophic Lateral Sclerosis Research (10 papers) and Alzheimer's disease research and treatments (6 papers). Loreto Martínez‐González is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (10 papers), Amyotrophic Lateral Sclerosis Research (10 papers) and Alzheimer's disease research and treatments (6 papers). Loreto Martínez‐González collaborates with scholars based in Spain, Italy and Chile. Loreto Martínez‐González's co-authors include Ana Martı́nez, Ángeles Martín‐Requero, Concepción Pérez, Carmen Gil, Eva de Lago, Daniel I. Pérez, Nuria E. Campillo, Sabrina Petralla, Barbara Monti and Fernando Benito Bartolomé and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Scientific Reports.

In The Last Decade

Loreto Martínez‐González

25 papers receiving 571 citations

Peers

Countries citing papers authored by Loreto Martínez‐González

Since Specialization

Citations

This map shows the geographic impact of Loreto Martínez‐González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loreto Martínez‐González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loreto Martínez‐González more than expected).

Fields of papers citing papers by Loreto Martínez‐González

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loreto Martínez‐González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loreto Martínez‐González. The network helps show where Loreto Martínez‐González may publish in the future.

Co-authorship network of co-authors of Loreto Martínez‐González

This figure shows the co-authorship network connecting the top 25 collaborators of Loreto Martínez‐González. A scholar is included among the top collaborators of Loreto Martínez‐González based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loreto Martínez‐González. Loreto Martínez‐González is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Screening Natural Phenolic Compounds for Blood‐Brain Barrier Permeability, Alongside GSK‐3 β , CK‐1 δ , and AChE Inhibition, for the Treatment of Alzheimer's Disease 2025 ·Drug Development Research ·(unknown), Şengül Dilem Doğan, Miyase Gözde Gündüz, Loreto Martínez‐González, Concepción Pérez, Ana Martı́nez	0
2	Structure-Based Discovery Targeting GSK-3α Reveals Potent Nanomolar Selective 4-Phenyl-1H-benzofuro[3,2-b]pyrazolo[4,3-e]pyridine Inhibitor with Promising Glioblastoma and CNS-Active Potential in Cellular Models 2025 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jane Alder, (unknown), Erwin Berenschot, Niels R. Tas, Arturo Susarrey‐Arce, Loreto Martínez‐González, Alina Oknianska, (unknown), Ana Martı́nez, Joseph M. Hayes	0
3	Modulation of Mitochondria–Endoplasmic Reticulum Contacts (MERCs) by Small Molecules as a New Strategy for Restoring Lipid Metabolism in an Amyotrophic Lateral Sclerosis Model 2025 ·Journal of Medicinal Chemistry ·(unknown), Hector Flores‐Romero, (unknown), Esther Masiá, (unknown), Jorge Montesinos, Loreto Martínez‐González, (unknown), Mar Orzáez, Marı́a J. Vicent, Carmen Gil, Estela Área-Gómez, Ana J. García‐Sáez, Ana Martı́nez	7
4	7-Amino-[1,2,4]triazolo[1,5-a][1,3,5]triazines as CK1δ inhibitors: Exploring substitutions at the 2 and 5-positions 2024 ·Bioorganic Chemistry ·(unknown), Davide Bassani, (unknown), Veronica Salmaso, (unknown), Filippo Prencipe, Tatiana Da Ros, Loreto Martínez‐González, Ana Martı́nez, Giampiero Spalluto, Stefano Moro, Stephanie Federico	0
5	Casein kinase 1 inhibitor avoids TDP-43 pathology propagation in a patient-derived cellular model of amyotrophic lateral sclerosis 2024 ·Neurobiology of Disease ·Eva P. Cuevas, Loreto Martínez‐González, (unknown), (unknown), (unknown), Amets Sáenz, Carmen Gil, Valle Palomo, Ángeles Martín‐Requero, Ana Martı́nez	9
6	Designing multitarget ligands for neurodegenerative diseases with improved permeability trough PLGA nanoencapsulation 2024 ·Biomedicine & Pharmacotherapy ·Vanesa Nozal, (unknown), Alfonso García‐Rubia, Loreto Martínez‐González, Eva P. Cuevas, Eva Carro, Valle Palomo, Ana Martı́nez	3
7	Prenylated Flavanone Isolated from Dalea Species as a Potential Multitarget-Neuroprotector in an In Vitro Alzheimer’s Disease Mice Model 2024 ·Neurotoxicity Research ·María Daniela Santi, Diego B. Carvalho, (unknown), (unknown), (unknown), Loreto Martínez‐González, Ana Martı́nez, (unknown), Ana Rey, Javier Giglio, Marı́a Gabriela Ortega, Eduardo Savio, Juan Andrés Abin‐Carriquiry, Florencia Arredondo	3
8	TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer’s disease patients 2023 ·Frontiers in Molecular Neuroscience ·Loreto Martínez‐González, Eva P. Cuevas, (unknown), Vanesa Nozal, Carmen Gil, Valle Palomo, Ángeles Martín‐Requero, Ana Martı́nez	9
9	Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis 2023 ·Expert Opinion on Investigational Drugs ·Loreto Martínez‐González, Ana Martı́nez	7
10	TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy 2022 ·Journal of Medicinal Chemistry ·Vanesa Nozal, Loreto Martínez‐González, (unknown), (unknown), Paula Santana, A. Chaikuad, Eva P. Cuevas, Stefan Knapp, Daniel Lietha, David Ramírez, Sabrina Petralla, Barbara Monti, Carmen Gil, Ángeles Martín‐Requero, Valle Palomo, Eva de Lago, Ana Martı́nez	28
11	Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis 2021 ·International Journal of Molecular Sciences ·Loreto Martínez‐González, (unknown), (unknown), (unknown), Eva de Lago, Ángeles Martín‐Requero, Ana Martı́nez	45
12	Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis 2020 ·European Journal of Medicinal Chemistry ·(unknown), Loreto Martínez‐González, (unknown), Nicole F. Liachko, Concepción Pérez, David Ramírez, Brian C. Kraemer, Ángeles Martín‐Requero, Daniel I. Pérez, Carmen Gil, Eva de Lago, Ana Martı́nez	37
13	Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment 2020 ·Scientific Reports ·Loreto Martínez‐González, Carmen Rodríguez‐Cueto, (unknown), Fernando Benito Bartolomé, Pol Andrés‐Benito, Isidró Ferrer, Carmen Gil, Ángeles Martín‐Requero, Javier Fernández‐Ruíz, Ana Martı́nez, Eva de Lago	42
14	Therapeutic potential of novel Cell Division Cycle Kinase 7 inhibitors on TDP‐43‐related pathogenesis such as Frontotemporal Lobar Degeneration (FTLD) and amyotrophic lateral sclerosis (ALS) 2020 ·Journal of Neurochemistry ·(unknown), Loreto Martínez‐González, (unknown), (unknown), (unknown), Eva P. Cuevas, Carmen Gil, Ana Martı́nez, Ángeles Martín‐Requero	23
15	Insights into real-time chemical processes in a calcium sensor protein-directed dynamic library 2019 ·Nature Communications ·(unknown), (unknown), María José Sánchez-Barrena, Ángeles Canales, (unknown), (unknown), Loreto Martínez‐González, Dolores Molero, María Encarnación Fernández-Valle, Elena Sáez, (unknown), (unknown), Sonsoles Martín‐Santamaría, (unknown), Alicia Mansilla, F. Javier Cañada, Jesús Jiménez‐Barbero, Ana Martı́nez, Ruth Pérez‐Fernández	17
16	Derivatives of the β-Crinane Amaryllidaceae Alkaloid Haemanthamine as Multi-Target Directed Ligands for Alzheimer’s Disease 2019 ·Molecules ·(unknown), (unknown), (unknown), Jan Korábečný, Daniela Hulcová, Jana Maříková, Tomáš Kučera, Loreto Martínez‐González, Martina Hrabinová, (unknown), Lucie Nováková, Angela De Simone, Radim Havelek, Lucie Cahlíková	26
17	Recapitulation of Pathological TDP-43 Features in Immortalized Lymphocytes from Sporadic ALS Patients 2018 ·Molecular Neurobiology ·(unknown), Loreto Martínez‐González, Fernando Benito Bartolomé, Siranjeevi Nagaraj, (unknown), Ana Martı́nez, Ángeles Martín‐Requero	27
18	Chameleon-like behavior of indolylpiperidines in complex with cholinesterases targets: Potent butyrylcholinesterase inhibitors 2018 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Carlos Roca, Víctor Sebastián-Pérez, Loreto Martínez‐González, Daniel I. Pérez, Concepción Pérez, Ángeles Canales, F. Javier Cañada, Nuria E. Campillo, Ivone Carvalho, Ana Martı́nez	18
19	A Focused Library of Psychotropic Analogues with Neuroprotective and Neuroregenerative Potential 2018 ·ACS Chemical Neuroscience ·Elisa Uliassi, Emiliano Peña‐Altamira, Aixa V. Morales, Francesca Massenzio, Sabrina Petralla, Michele Rossi, Marinella Roberti, Loreto Martínez‐González, Ana Martı́nez, Barbara Monti, María Laura Bolognesi	19
20	Interference of the complex between NCS-1 and Ric8a with phenothiazines regulates synaptic function and is an approach for fragile X syndrome 2017 ·Proceedings of the National Academy of Sciences ·Alicia Mansilla, Antonio Chaves-Sanjuán, Nuria E. Campillo, (unknown), Loreto Martínez‐González, Lourdes Infantes, Juana María González-Rubio, Carmen Gil, Santiago Conde, Efthimios M. C. Skoulakis, Alberto Ferrús, Ana Martı́nez, María José Sánchez-Barrena	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact